Morgan Stanley’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,090
| Closed | -$1K | – | 7655 |
|
|
2020
Q4 | $1K | Buy |
2,090
+2,000
| +2,222% | +$1.01K | ﹤0.01% | 7014 |
|
|
2020
Q3 | $0 | Sell |
90
-40,447
| -100% | -$29.1K | ﹤0.01% | 6916 |
|
|
2020
Q2 | $28K | Buy |
40,537
+19,969
| +97% | +$16.1K | ﹤0.01% | 5905 |
|
|
2020
Q1 | $18K | Sell |
20,568
-94,263
| -82% | -$135K | ﹤0.01% | 5854 |
|
|
2019
Q4 | $189K | Buy |
114,831
+91,041
| +383% | +$137K | ﹤0.01% | 5438 |
|
|
2019
Q3 | $26K | Buy |
23,790
+21,461
| +921% | +$24.8K | ﹤0.01% | 5940 |
|
|
2019
Q2 | $2K | Sell |
2,329
-172,247
| -99% | -$219K | ﹤0.01% | 6493 |
|
|
2019
Q1 | $252K | Sell |
174,576
-122,970
| -41% | -$182K | ﹤0.01% | 4945 |
|
|
2018
Q4 | $350K | Sell |
297,546
-12,813
| -4% | -$19K | ﹤0.01% | 5020 |
|
|
2018
Q3 | $420K | Buy |
310,359
+117,615
| +61% | +$186K | ﹤0.01% | 5096 |
|
|
2018
Q2 | $441K | Buy |
192,744
+93,873
| +95% | +$181K | ﹤0.01% | 5182 |
|
|
2018
Q1 | $149K | Buy |
98,871
+4,707
| +5% | +$5.51K | ﹤0.01% | 5588 |
|
|
2017
Q4 | $72K | Buy |
94,164
+35,497
| +61% | +$31.7K | ﹤0.01% | 5734 |
|
|
2017
Q3 | $68K | Sell |
58,667
-132,519
| -69% | -$167K | ﹤0.01% | 5688 |
|
|
2017
Q2 | $333K | Buy |
191,186
+13,473
| +8% | +$28.6K | ﹤0.01% | 5043 |
|
|
2017
Q1 | $469K | Buy |
177,713
+10,034
| +6% | +$36K | ﹤0.01% | 4877 |
|
|
2016
Q4 | $713K | Buy |
167,679
+159,289
| +1,899% | +$525K | ﹤0.01% | 4697 |
|
|
2016
Q3 | $22K | Buy |
8,390
+7,952
| +1,816% | +$18.3K | ﹤0.01% | 5892 |
|
|
2016
Q2 | $1K | Sell |
438
-5,457
| -93% | -$11.1K | ﹤0.01% | 6460 |
|
|
2016
Q1 | $14K | Sell |
5,895
-3,936
| -40% | -$8.9K | ﹤0.01% | 6039 |
|
|
2015
Q4 | $34K | Sell |
9,831
-2,943
| -23% | -$14.1K | ﹤0.01% | 5862 |
|
|
2015
Q3 | $78K | Sell |
12,774
-2,120
| -14% | -$14.4K | ﹤0.01% | 5544 |
|
|
2015
Q2 | $99K | Sell |
14,894
-101,794
| -87% | -$687K | ﹤0.01% | 5597 |
|
|
2015
Q1 | $830K | Buy |
+116,688
| New | +$880K | ﹤0.01% | 4269 |
|
Other funds holding GEN
IC
TRCT
Morgan Stanley's GEN Position: Q1 2021 in Review
Morgan Stanley sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 2,090 shares — an estimated $1K sold.
Morgan Stanley first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $830K in Q1 2015. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.
- Morgan Stanley reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
- Morgan Stanley sold 2,090 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $1K.
- Morgan Stanley first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
- Morgan Stanley's Genesis Healthcare, Inc. position peaked at $830K in Q1 2015.
- 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.